Aridis Pharma enters option agreement with Serum Institute of India - The Pharma Letter

Aridis Pharma enters option agreement with Serum Institute of India  The Pharma Letter

US biopharma firm Aridis Pharmaceuticals (Nasdaq: ARDA) announced today that it has entered into an option agreement with the Serum International BV ...



Comments

Popular posts from this blog

Глушители. Приборы бесшумной стрельбы